发明授权
US07858594B2 Crystalline and amorphous forms of beta-L-2′-deoxythymidine
有权
β-L-2'-deoxythymidine的结晶和无定形形式
- 专利标题： Crystalline and amorphous forms of beta-L-2′-deoxythymidine
- 专利标题（中）： β-L-2'-deoxythymidine的结晶和无定形形式
-
申请号： US12505839申请日： 2009-07-20
-
公开(公告)号： US07858594B2公开(公告)日： 2010-12-28
- 发明人: David Jonaitis , Richard Storer
- 申请人： David Jonaitis , Richard Storer
- 申请人地址： CH Basel
- 专利权人： Novartis Pharma AG
- 当前专利权人： Novartis Pharma AG
- 当前专利权人地址： CH Basel
- 代理机构： Dilworth & Barrese, LLP
- 代理商 Ann R. Pokalsky, Esq.
- 主分类号： A01N43/04
- IPC分类号： A01N43/04 ; A61K31/70
摘要：
Physical forms of beta-L-2′-deoxythymidine are disclosed that can be characterized by physical appearance, purity levels, Infra-Red and Raman spectroscopy, X-ray powder diffraction patterns, thermal properties, and methods of manufacture. These forms of beta-L-2′-deoxythymidine can be used in the manufacture of other forms of beta-L-2′-deoxythymidine, or in pharmaceutical compositions. Particularly preferred uses are in the treatment of hepatitis B.
公开/授权文献
- US20100048504A1 CRYSTALLINE AND AMORPHOUS FORMS OF BETA-L-DEOXYTHYMIDINE 公开/授权日：2010-02-25
信息查询
IPC分类:
